Yüklüyor......
Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study
OBJECTIVE: Gabapentin and its prodrug are candidate therapeutic agents for akathisia. An open-label pilot study was conducted to investigate the therapeutic potential of gabapentin enacarbil (GE) for akathisia. METHODS: In an open-labeled investigator-initiated clinical trial, nine outpatients with...
Kaydedildi:
| Yayımlandı: | Neuropsychiatr Dis Treat |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6257366/ https://ncbi.nlm.nih.gov/pubmed/30538475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S184081 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|